LAS VEGAS, Oct. 16, 2019 /PRNewswire/ -- GNCC Capital, Inc. (OTC: GNCP) ("The Company" or "GNCC") confirms that the related party transaction referred to October 10, 2019 has been ratified.Your recently appointed GNCC Directors confirm that at this time, GNCC will focus its activities in South Africa t

NORTH CHICAGO, Ill., Oct. 16, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of October 14, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,820,152 shares of common stock with a par value of $0.01

EVANSTON, Ill., Oct. 16, 2019 /PRNewswire/ -- Recent research compiled by the American Massage Therapy Association on massage therapy for cancer patients continu

GENEVA, Oct. 16, 2019 /PRNewswire/ -- Andrew Alliance and Brooks Life Sciences today announced a co-marketing relationship that will enable Brooks Life Sciences consumables to be added to Andrew Alliance's groundbreaking OneLab software environment, developed to support the design, execution and sharing of lif

SHANGHAI, Oct. 16, 2019 /PRNewswire/ -- dMed Biopharmaceutical Co., Ltd. recently announced completion of a nearly US$50 million Series B financing, led by Vivo Capital and joined by Legend Capital, Qiming Venture Partners and Lilly Asia Ventures. After this round of financing, dMed will accelerate expansion of its comprehensive clinical ope

WASHINGTON, Oct. 16, 2019 /PRNewswire/ -- U.S. News & World Report, the global authority in hospital rankings and

HYDERABAD, India, Oct. 15, 2019 /PRNewswire/ -- LifeNet Health's Dermacell AWM®, the world's most-advanced acellular dermal matrix (ADM) for wound treatment, is the first human ADM available in India. This introduction provides access to proven therapy for millions of patients in India suffe

ORLANDO, Fla., Oct. 15, 2019 /PRNewswire/ -- In June 2019, Orlando, FL-based nScrypt announced a

LAFAYETTE, Louisiana, Oct. 15, 2019 /PRNewswire/ -- RedHawk Holdings Corp. (OTC: SNDD) ("RedHawk" or the "Company") a diversified holding company engaged in sales and distribution of medical devices, branded generic pharmaceutical drugs, commercial real estate investment and leasing, point of entry full-body security systems, and specialized financial

CURIOX BIOSYSTEMS, is an A*STAR spinoff company, that develops bioinstrumentation solutions used in cell analysis and therapy for the pharmaceutical and biotech industries. The company has successfully penetrated the USA, PRC, Korean and European markets and also secured a Series B funding of US$15M from Korean biotech